Nuvation Bio Inc.
NUVB
$6.22
$0.121.97%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -61.93% | 98.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -61.93% | 98.80% | |||
| Cost of Revenue | 58.09% | 368.41% | |||
| Gross Profit | -71.24% | 90.30% | |||
| SG&A Expenses | 11.18% | -5.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.25% | 4.54% | |||
| Operating Income | -1,415.02% | 111.40% | |||
| Income Before Tax | -1,264.35% | 114.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,264.35% | 114.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,264.35% | 114.75% | |||
| EBIT | -1,415.02% | 111.40% | |||
| EBITDA | -1,243.31% | 113.19% | |||
| EPS Basic | -1,262.58% | 114.58% | |||
| Normalized Basic EPS | -1,086.60% | 114.61% | |||
| EPS Diluted | -1,262.58% | 114.58% | |||
| Normalized Diluted EPS | -1,086.60% | 114.61% | |||
| Average Basic Shares Outstanding | 0.41% | 0.87% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||